Your browser doesn't support javascript.
loading
Sorafenib plus hepatic arterial infusion chemotherapy with cisplatin versus sorafenib for advanced hepatocellular carcinoma: randomized phase II trial.
Ikeda, M; Shimizu, S; Sato, T; Morimoto, M; Kojima, Y; Inaba, Y; Hagihara, A; Kudo, M; Nakamori, S; Kaneko, S; Sugimoto, R; Tahara, T; Ohmura, T; Yasui, K; Sato, K; Ishii, H; Furuse, J; Okusaka, T.
Afiliação
  • Ikeda M; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa masikeda@east.ncc.go.jp.
  • Shimizu S; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa.
  • Sato T; Department of Biostatistics, Kyoto University School of Public Health, Kyoto.
  • Morimoto M; Department of Hepatobiliary and Pancreatic Medical Oncology, Kanagawa Cancer Center, Yokohama.
  • Kojima Y; Department of Gastroenterology, National Center for Global Health and Medicine Center Hospital, Tokyo.
  • Inaba Y; Department of Diagnostic and Interventional Radiology, Aichi Cancer Center Hospital, Nagoya.
  • Hagihara A; Department of Hepatology, Osaka City University Hospital, Osaka.
  • Kudo M; Department of Gastroenterology and Hepatology, Kinki University School of Medicine, Osaka.
  • Nakamori S; Department of Hepatobiliary and Pancreatic Surgery, Osaka National Hospital, Osaka.
  • Kaneko S; Department of Gastroenterology, Kanazawa University Hospital, Kanazawa.
  • Sugimoto R; Department of Hepato-Biliary-Pancreatology, National Hospital Organization Kyushu Cancer Center, Fukuoka.
  • Tahara T; Department of Gastroenterology, Saiseikai Utsunomiya Hospital, Tochigi.
  • Ohmura T; Department of Gastroenterology, Sapporo Kosei General Hospital, Sapporo.
  • Yasui K; Department of Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Kyoto.
  • Sato K; Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto.
  • Ishii H; Clinical Research Center, Shikoku Cancer Center, Matsuyama.
  • Furuse J; Department of Medical Oncology, Kyorin University, Tokyo.
  • Okusaka T; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan.
Ann Oncol ; 27(11): 2090-2096, 2016 11.
Article em En | MEDLINE | ID: mdl-27573564
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Cisplatino / Niacinamida / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Cisplatino / Niacinamida / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article